Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcineurin inhibitor monotherapy versus sirolimus monotherapy after liver transplantation in hepatitis C patients with hepatic fibrosis
ISRCTN26350966Phase 4Terminated
- Sponsor
- Addenbrooke's Hospital (UK)
- Start
- May 2010
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of sirolimus in hepatitis C virus infection and hepatic fibrosis (2 arms), sponsored by Addenbrooke's Hospital (UK). Primary endpoint: Liver biopsy fibrosis score. Started May 2010; status: terminated.
02
Drugs
sirolimus
03
Conditions
hepatitis C virus infectionhepatic fibrosis
Beyond the preview
Go deeper on ISRCTN26350966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26350966.